O'Donnell Niall

SEC CIK: 0001780235

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

OKUR OnKure Therapeutics, Inc.Directoras of Jun 8, 2023
SPRB Spruce Biosciences, Inc.Directoras of May 26, 2023
MIRM Mirum Pharmaceuticals, Inc.Directoras of Nov 15, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists O'Donnell Niall as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

SPRB Spruce Biosciences, Inc.

Director2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
May 16, 2023 (view filing)	Feb 16	89 daysLate	O'Donnell NiallDirector	PPurchase	+630.4K	$3.17	+$2.00M	+90.6%1.33M after
May 16, 2023 (view filing)	Feb 16	89 daysLate	O'Donnell NiallDirector	PPurchase	+472.8K	–	–	–472.8K after	Derivative

OKUR OnKure Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
May 10, 2023 (view filing)	May 8	2 days	O'Donnell NiallDirector	PPurchase	+125.0K	$8.00	+$1.00M	+6.1%2.19M after

MIRM Mirum Pharmaceuticals, Inc.